American Red Cross: Celebrate Black History Month by Participating in a ‘Sleeves Up’ Campaign

February is Black History Month  – a time to honor the significant achievements of Black Americans while making an impact today. This year’s theme focuses on the importance of Black health and wellness. The American Red Cross is honoring the legacy of Dr. Charles Drew, an African American surgeon, and researcher who pioneered new methods for collecting, preserving, and distributing blood, as well as storing blood plasma for transfusion. We work to celebrate his advancements by putting a challenge out to the entire Georgia Region.

“Dr. Drew’s work with the Red Cross Blood Program helped save the lives of hundreds of thousands of people,” said Dee Dixon, CEO of Georgia’s Red Cross. “With blood transfusions remaining one of the most critical treatments for patients with chronic illnesses such as sickle cell, I invite Georgians everywhere to continue Dr. Drew’s lifesaving legacy by rolling up a sleeve to give blood during Black History Month.”

No bloodmobile or space is needed to answer this challenge, making it especially convenient for students and organizations to get involved. Simply create your campaign online, and send an invitation to your friends and family members anywhere in Georgia to join you in donating blood and saving lives.

Participants can visit  www.redcrossblood.org  to enter their zip code and find/book a convenient blood donation appointment in February or upcoming months.

Once participants are ready to roll up a sleeve, we want to see it! We invite all campaign blood donors to snap a picture and share it on social media using the hashtags:  #TeamUp4SickleCellGA & #BlackBloodDonorsNeeded

Calendar opportunities for launching an inspiring Sleeves Up Campaign during Black History Month / American Heart Month include:

  • African Heritage and Health Week – Feb. 1-7
  • Rosa Parks Day – Feb. 5
  • National Black HIV/AIDS Awareness Day – Feb. 7
  • National Donor Day – Feb. 14
  • Frederick Douglass Day – Feb. 14
  • National Black Girl Magic Day – Feb. 15
  • World Day of Social Justice – Feb. 20
  • Black Lives Matter Day – Feb. 26
  • Rare Disease Day – Feb. 28

Blood donations from everyone remain essential to the health of communities. However, African American donors play a critical role in meeting the need for blood – especially for those with sickle cell disease who often rely on closely matched blood products for regular transfusions. Individuals of all blood types are urged to make an appointment now to give blood or platelets in the weeks ahead by using the  Red Cross Blood DonorApp , visiting  RedCrossBlood.org , or calling  1 800-RED CROSS (1-800-733-2767) .

 As an extra thank-you during Black History Month, those who come to give in February will receive a $10  Amazon.com  Gift Card via email,  thanks to Amazon.

The Red Cross is currently providing free sickle cell trait screening on all donations from self-identified African American donors in addition to a free mini health screening with insights on pulse, blood pressure and hemoglobin levels.

About the American Red Cross:

The American Red Cross shelters, feeds, and provides emotional support to victims of disasters; supplies about 40 percent of the nation’s blood; teaches skills that save lives; provides international humanitarian aid; and supports military members and their families. The Red Cross is a not-for-profit organization that depends on volunteers and the generosity of the American public to perform its mission. For more information, please visit  redcross.org  or  cruzrojaamericana.org .

May 5, 2026
New coalition forms to develop a national innovation roadmap to strengthen and extend  America’s global leadership in biotechnology
April 30, 2026
BioMADE Announces $21.4 Million Invested in 14 Projects to Develop the U.S. Bioindustrial Manufacturing Industry and Advance National Security Priorities
April 17, 2026
April 17, 2026 - Nutrivert Inc., a developer of non-antibiotic replacements for antibiotic growth promoters in livestock, today announced it has completed the first close, raising $2.375 million, of its Series A-2 funding round of $6 million. The round was led by global animal health investor Arrow Ventures with participation from other investors. The funding will be used to further develop Nutrivert’s manufacturing, human food safety and target animal safety and efficacy packages for the company’s lead product Nutrivert LDPP. Nutrivert LDPP is a proprietary, novel, orally available, lipidated synthetic enantiomeric desmuramyl analog of muramyl dipeptide, the smallest conserved immunoactive component of bacterial peptidoglycan. LDPP has no antibacterial effect but has consistently promoted growth and improved feed efficiency in pig studies. LDPP binds to the mammalian NOD2 receptor and is the only NOD2 ligand reported to inhibit the inflammatory signal NF-κB. In pilot studies, LDPP rescued 70kg pigs from an otherwise lethal dose of porcine reproductive and respiratory syndrome virus (PRRSV) and abrogated influenza disease symptoms in piglets. The Company intends to develop LDPP for all major livestock species worldwide. Patents have been granted in most major markets. The global antibiotic growth promoter market is worth an estimated $5.8 billion. Approximately 73% of all antibiotics are fed to livestock. The market is believed to be the world’s largest drug market by volume, with ~100,000 tons of active pharmaceutical ingredient administered annually. FDA’s latest data, for 2024, show a 13% rise in U.S. livestock antibiotic use since 2017. The Food and Agriculture Organization reports that livestock antibiotics are mostly given to speed animal growth. Regulators and non-governmental organizations have called for reduction of antibiotic use in livestock, citing concerns that the global, intensive use of antibiotics, often at subtherapeutic doses, selects for antimicrobial resistance: bacteria that are “immune” to antibiotics and that therefore pose a threat to public health. Spillovers of antibiotic-resistant bacteria from livestock to humans have been documented. “Nutrivert LDPP has consistently improved feed efficiency in pigs without antibiotics,” said Bernhard Kaltenboeck, CSO. “We are excited to have the support of Arrow Ventures and our other investors in bringing a new tool that will help producers reduce production costs and reduce selection pressure for antimicrobial resistance.” About Nutrivert LDPP: LDPP is an investigational compound currently undergoing clinical evaluation. It has not been approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other global regulatory authority for any indication. The safety and efficacy of LDPP have not been established. Any mention of potential use is based on preliminary data and does not guarantee future regulatory clearance or commercial availability.
MORE POSTS